ProRx recalls Semaglutide injections due to lack of sterility assurance. Affected units have NDC 84139-225-02 and lot PRORX052125-4. No remedy specified in recall notice.
Lack of Assurance of Sterility
ProRx is recalling Semaglut: 5 mg/2 mL injections because they may not be sterile. This could lead to infections if injected. The recall covers specific lot numbers and manufacturing dates.
The injections may not be sterile, which can cause infections at the injection site. This is a serious risk because the product is used directly into the body.
People who have received the Semaglutide injection vials with NDC 84139-225-02 and lot PRORX052125-4. Those using the product for weight management under prescription are most at risk.
Check for the NDC code 84139-225-02 and lot number PRORX052125-4 on the vial label. The product was manufactured by ProRx at 619 Jeffers Cir, Exton, PA.
Look for the NDC code 84139-225-02 and lot number PRORX052125-4 on the vial.
The recall notice does not specify any remedy.
The product may not be sterile, which could lead to infections at the injection site.
Check the vial label for NDC 84139-225-02 and lot number PRORX052125-4.
We’ve drafted a message you can send ProRx to request your refund or repair — edit it as you like.
Subject: Recall D-0119-2026 — ProRx ProRx Hello, I own a ProRx that is covered by recall D-0119-2026 from ProRx. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
